ESR1 and breast carcinoma: Non-genomic effects of steroids are known to be mediated by membrane-associated or cytoplasmic ERa, PR or AR in many types of cells, including breast cancer, activating kinase pathways such as ERK or PI3K/AKT (reviewed in [51,52].